Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.
about
Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6)Clinical characteristics and treatment of short QT syndrome.Short QT syndrome. Genotype-phenotype correlationsReduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT.[Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies].Short QT Syndrome - Review of Diagnosis and Treatment.Congenital short QT syndrome.Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.Short QT syndrome: from bench to bedside.Short QT syndrome: mechanisms, diagnosis and treatment.Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel.Strategies for the prevention and treatment of sudden cardiac death.Total failure to sense ventricular fibrillation with inappropriate defibrillator sensitivity adjustment.Brief review of the recently described short QT syndrome and other cardiac channelopathies.Pharmacological approach to the treatment of long and short QT syndromesThe hERG potassium channel as a therapeutic target.Computational cardiology and risk stratification for sudden cardiac death: one of the grand challenges for cardiology in the 21st century.The genetic and clinical features of cardiac channelopathies.The short QT syndrome.Fast T Wave Detection Calibrated by Clinical Knowledge with Annotation of P and T Waves.Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.In silico investigation of a KCNQ1 mutation associated with short QT syndrome.T Wave Safety Margin during the Process of ICD Implantation As a Novel Predictor of T Wave Oversensing.Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome?Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutants.Use of a subcutaneous ICD in a patient with short QT syndrome.Sudden cardiac death in the young: how can disease recognition and prevention in family members be improved?Fatal inappropriate ICD shock.Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing.In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.Inappropriate implantable cardioverter defibrillator therapy in the short QT syndrome: old problem in a new disease.Quinidine in short QT syndrome: an old drug for a new disease.
P2860
Q28117761-36DF7733-F957-45EF-96FC-7BF9F7924343Q33152955-79C318F0-A4C1-4234-A492-376D6BC03A58Q33153179-6B57012C-2B5C-4EA3-B389-18A15C88BADCQ33155155-DB01E8F4-A3D2-4168-9F1D-1E94AC1EA584Q33157573-C8424E2F-29AE-4DFB-82CB-B0D935231B3CQ33165762-BC064A5B-0DC0-4485-93CF-337E3692AB2BQ33166770-6865F4FF-4B12-4532-8337-D99D84F38E64Q33609619-E6E3F658-3848-4ECC-94D7-9B68F0AF6F40Q33776456-CBFA2405-71A7-4545-8A50-8E4F3C27864CQ34102891-9B8B1FC1-91A7-4763-BF98-C5EB23703AA0Q34464676-24E8215D-9D81-4D88-A39F-9862423AA6C0Q34540719-E3499390-E50B-4C16-B238-113811273CA3Q35560103-829A6351-4307-4C9A-BAE8-00715172B928Q35907157-BBEA7704-4864-4676-9864-9D95F2C8E5B8Q36200433-8CD689E0-BEB3-49A4-846E-9DBBC0D349AEQ36660810-7B857015-1163-4F09-AF51-919CD558553DQ36734932-A26B2C88-4B22-4324-B2E3-5A536E07937DQ37466831-E681EFD4-35CB-40FA-B89F-1D74871D2F97Q37770572-A7F2FCF7-6C00-4D06-A89A-4A7FE2E1980CQ37864963-9798918A-1E34-4EDD-87AD-74E9541B36D2Q40298637-008719D9-6268-4227-8F57-6C7CF3D296B7Q41140521-68E8ED42-3333-4C0B-9951-8113D0A0A01CQ41437149-B396B5D5-B861-4D69-AA8A-BDF256F103F1Q41619915-1C315D48-71EC-4AAF-B5D3-F8BC5B0DED0EQ42347980-77D73C90-2AD7-4931-8872-F02E9B394031Q42768918-7CBC9E0E-2A97-42E2-9D82-4FEFBE65E7B2Q43098613-89665A78-6386-476F-86AA-E987128EA492Q44701011-A6DA7C5B-1D9D-4EA2-8DD9-AC0DF838456EQ48264022-C820B729-1127-43FE-AA79-E2A4CF348106Q50973667-529FA60A-508D-430E-8C99-542DEC0BE506Q51206866-D9E409CD-2214-4F77-B3B2-A152F3E15DFAQ51741077-1F6C97B7-3C8F-4B04-A3E2-DD9005EA27A4Q51784055-8FF0628B-33E4-4F4A-9912-AA833BDA383BQ55043965-594747BF-9A61-4F59-9211-2DE213C196DA
P2860
Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Congenital short QT syndrome a ...... inappropriate shock delivery.
@ast
Congenital short QT syndrome a ...... inappropriate shock delivery.
@en
type
label
Congenital short QT syndrome a ...... inappropriate shock delivery.
@ast
Congenital short QT syndrome a ...... inappropriate shock delivery.
@en
prefLabel
Congenital short QT syndrome a ...... inappropriate shock delivery.
@ast
Congenital short QT syndrome a ...... inappropriate shock delivery.
@en
P2093
P2860
P50
P1476
Congenital short QT syndrome a ...... inappropriate shock delivery.
@en
P2093
Carla Giustetto
Florenzo Gaita
Francesca Bianchi
Urs Bauersfeld
P2860
P304
P356
10.1046/J.1540-8167.2003.03278.X
P577
2003-12-01T00:00:00Z